The Rapid Shallow Breathing Index (RSBI) is a Widely Used Predictor for Weaning Patients From Mechanical Ventilation This Study Aims to Determine the Predictive Value of RSBI Measurements for Extubation Success in Mechanically Ventilated ICU Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age22+
SponsorAin Shams University

About this trial

Early extubation in ICU patients is crucial for reducing complications of prolonged ventilation, including morbidity and mortality. The Rapid Shallow Breathing Index (RSBI) is a widely used predictor for weaning patients from mechanical ventilation. This study aims to determine the predictive value of RSBI measurements for extubation success in mechanically ventilated ICU patients

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

• Adults > 22 years.

FiO₂ ≤ 0.4, PEEP ≤ 8 cmH₂O, PaO₂/FiO₂ ≥ 200 mmHg.

Respiratory rate ≤ 35 breaths/min, pH > 7.30.

Hemodynamic stability (HR ≤ 120 bpm, SBP 90-160 mmHg).

Disqualifiers

Age <22 years.

Refusal of informed consent.

Altered mental status (e.g., traumatic brain injury).

Hemodynamic instability or deep sedation (RASS ≤ -2).

Trial population

mechnically ventilated patient eligable for extubation

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Extubation success (no reintubation/adjuvant support within 48h).

no reintubation or adjuvant oxygen therapy

Time frame
48 hour

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.